Peer support models for people with a history of injecting drug use undertaking assessment and treatment for hepatitis C virus infection

Clinical Infectious Diseases

Volumn 57, Issue SUPPL.2, 2013, Pages

  Crawford, Sione ^a   Bath, Nicky ^a  

^a Programs and Services   (Australia)

Author keywords

Drug users; HCV; Opiate substitution; People who use drugs; PWID

Indexed keywords

ABSTINENCE; ARTICLE; CHRONIC DISEASE; CLINICAL ASSESSMENT; DRUG USE; GROUP THERAPY; HEALTH CARE DELIVERY; HEALTH PROMOTION; HEALTH SERVICE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTERPERSONAL COMMUNICATION; KNOWLEDGE; LOCUS OF CONTROL; MEDICAL HISTORY; MISCELLANEOUS NAMED GROUPS; OPIATE SUBSTITUTION TREATMENT; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PEER GROUP; PEOPLE WHO INJECT DRUG; PRIORITY JOURNAL; SELF HELP; SUBSTANCE ABUSE; THERAPEUTIC COMMUNITY;

DRUG USERS; HCV; OPIATE SUBSTITUTION; PEOPLE WHO USE DRUGS; PWID;

HEPATITIS C; HUMANS; PEER GROUP; SOCIAL SUPPORT; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84881019269     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit297     Document Type: Article

References (26)

1. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. The Lancet Infectious Diseases 2005; 5: 558-67.
2. Nelson PK, Mathers BM, Cowie B, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 2011; 378: 571-83.
3. Dore GJ. The changing therapeutic landscape for hepatitis C. The Medical Journal of Australia 2012; 196: 629-32.
4. Grebely J, Tyndall MW. Management of HCV and HIV infections among people who inject drugs. Current Opinion in HIV and AIDS 2011; 6: 501-7.
5. Merrill JO, Rhodes LA, Deyo RA, Marlatt GA, Bradley KA. Mutual mistrust in the medical care of drug users: the keys to the "narc" cabinet. Journal of General Internal Medicine 2002; 17: 327-33.
6. Rance J, Newland J, Hopwood M, Treloar C. The politics of place (ment): problematising the provision of hepatitis C treatment within opiate substitution clinics. Social Science & Medicine 2012; 74: 245-53.
7. Dimova RB, Zeremski M, Jacobson IM, Hagan H, Des Jarlais DC, Talal AH. Determinants of hepatitis C virus treatment completion and efficacy in drug users assessed by meta-analysis. Clinical Infectious Diseases 2013; 56: 806-16.
8. Edlin BR, Carden MR. Injection drug users: the overlooked core of the hepatitis C epidemic. Clinical Infectious Diseases 2006; 42: 673-6.
9. Hopwood M, Treloar C. The drugs that dare not speak their name: injecting and other illicit drug use during treatment for hepatitis C infection. The International Journal on Drug Policy 2007; 18: 374-80.
10. Hopwood M, Treloar C. The 3D project: diagnosis, disclosure, discrimination & living with hepatitis C. National Centre in HIV Social Research, University of New SouthWales, Australia, 2003.
11. Stigma and discrimination around HIV and HCV in healthcare settings: Australasian society for HIV medicine and the national centre in HIV social research, 2012.
12. Doab A, Treloar C, Dore GJ. Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia. Clin Infect Dis 2005; 40(Suppl 5): S313-20.
13. Parent N, Fortin F. A randomized, controlled trial of vicarious experience through peer support for male first-time cardiac surgery patients: impact on anxiety, self-efficacy expectation, and self-reported activity. Heart & Lung : The Journal of Critical Care 2000; 29: 389-400.
14. Wilson W, Pratt C. The impact of diabetes education and peer support upon weight and glycemic control of elderly persons with noninsulin dependent diabetes mellitus (NIDDM). American Journal of Public Health 1987; 77: 634-5.
15. Hoey LM, Ieropoli SC, White VM, Jefford M. Systematic review of peer-support programs for people with cancer. Patient Education and Counseling 2008; 70: 315-37.
16. Pearson CR, Micek MA, Simoni JM, et al. Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique. Journal of Acquired Immune Deficiency Syndromes 2007; 46: 238-44.
17. Norman J, Walsh NM, Mugavin J, et al. The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users. Harm Reduction Journal 2008; 5:8.
18. Alavi M, Grebely J, Micallef M, et al. Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opiate substitution setting: the ETHOS study. Clin Infect Dis 2013; In Press.
19. Rance J, Treloar C. Integrating Treatment: Key findings from a qualitative evaluation of the Enhancing Treatment of Hepatitis C in Opiate Substitution Settings (ETHOS) study. Sydney: National Centre in HIV Social Research, 2012.
20. Musgrove SM. NUAA's ETHOS Projects: The story of a hep C peer support worker & his clinic. In: 2nd International Symposium on Hepatitis in Substance Users. Brussels, Belgium, 2011.
21. Sylvestre DL, Zweben JE. Integrating HCV services for drug users: a model to improve engagement and outcomes. The International Journal on Drug Policy 2007; 18: 406-10.
22. Stein MR, Soloway IJ, Jefferson KS, Roose RJ, Arnsten JH, Litwin AH. Concurrent group treatment for hepatitis C: implementation and outcomes in a methadone maintenance treatment program. Journal of Substance Abuse Treatment 2012; 43: 424-32.
23. Grebely J, Knight E, Genoway KA, et al. Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support. European Journal of Gastroenterology & Hepatology 2010; 22: 270-7.
24. Charlebois A, Lee L, Cooper E, Mason K, Powis J. Factors associated with HCV antiviral treatment uptake among participants of a community- based HCV programme for marginalized patients. Journal of Viral Hepatitis 2012; 19: 836-42.
25. Galindo L, Maginnis T, Wallace G, Hansen A, Sylvestre D. Education by peers is the key to success. The International Journal on Drug Policy 2007; 18: 411-6.
26. Treloar C, Newland J, Rance J, Hopwood M. Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals. Journal of Viral Hepatitis 2010; 17: 839-44.